Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis

NCT05835518 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.

NCT NCT05835518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05835518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
Lead sponsor
Yuhan Corporation
Phase
Observational
Overall status
Recruiting
Start date
January 26, 2023
Completion date
August 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, rheumatoid arthritis